CONSOLIDATED STATEMENTS OF EQUITY - USD ($)	Total	Series A Preferred	Series B1 Preferred Stock	Series B Preferred Stock	Common Stock	Common Stock Series A Preferred	Common Stock Series B1 Preferred Stock	Common Stock Series B Preferred Stock	Preferred stock Series A Preferred	Preferred stock Series C Preferred	Additional Paid-In Capital	Additional Paid-In Capital Series B1 Preferred Stock	Additional Paid-In Capital Series B Preferred Stock	Retained Earnings	Retained Earnings Series B Preferred Stock	Non-controlling Interest
Beginning balance (in shares) at Dec. 31, 2020					45,554,841				419,859	0
Beginning balance at Dec. 31, 2020	$ 5,924,749				$ 45,555				$ 420	$ 0	$ 94,569,674			$ (90,008,778)		$ 1,317,878
Increase (Decrease) in Stockholders' Equity
Exercise of options/B1 warrants (in shares)					22,992		1,079,753
Exercise of options/ B1 warrants	0		$ 2,757,957		$ 23		$ 1,080				(23)	$ 2,756,877
Exchanges of Series B Preferred stock to common (in shares)								2,359,494
Exchanges of Series B Preferred stock to common				$ 4,747,250				$ 2,359					$ 4,114,570		$ 630,321
Share based compensation expense	150,514										150,514
Conversion of Series B Preferred stock to common (in shares)								638,224		0
Conversion of Series B Preferred stock to common				$ 1,978,494				$ 638		$ 0			$ 1,977,856
Conversion of Series B1 Preferred stock to common (in shares)							2,087,195
Conversion of Series B1 Preferred stock to common			3,256,024				$ 2,087					3,253,937
Dividends on Series B and B1	(372,183)													(372,183)
Accretion of discount on Series B and B1	(223,727)		(223,727)											(223,727)
Accretion of redeemable non-controlling interest to redemption value	(373,748)													(373,748)
Net income (loss)	2,965,338													974,369		1,990,969
Less: amount attributable to redeemable non-controlling interest	(1,542,402)															(1,542,402)
Ending balance (in shares) at Mar. 31, 2021					51,742,499				419,859	0
Ending balance at Mar. 31, 2021	19,268,266				$ 51,742				$ 420	$ 0	106,823,405			(89,373,746)		1,766,445
Beginning balance (in shares) at Dec. 31, 2021					63,287,965				385,601	0
Beginning balance at Dec. 31, 2021	30,067,097				$ 63,288				$ 386	$ 0	138,620,254			(110,614,035)		1,997,204
Increase (Decrease) in Stockholders' Equity
Exercise of options/B1 warrants (in shares)					60,000		1,112,728
Exercise of options/ B1 warrants	75,600		$ 0		$ 60		$ 1,113				75,540	$ (1,113)
Share based compensation expense	249,940										249,940
Reclassification of derivative liabilities	78,789,472										78,789,472
Conversion of Series B Preferred stock to common (in shares)						5,041			(5,041)
Conversion of Series B Preferred stock to common		$ 0				$ 5			$ (5)
Accretion of redeemable non-controlling interest to redemption value	(421,399)													(421,399)
Net income (loss)	(808,867)													(4,547,456)		3,738,589
Less: amount attributable to redeemable non-controlling interest	(3,768,535)															(3,768,535)
Ending balance (in shares) at Mar. 31, 2022					64,465,734				380,560	0
Ending balance at Mar. 31, 2022	$ 104,183,308				$ 64,466				$ 381	$ 0	$ 217,734,093			$ (115,582,890)		$ 1,967,258